Could Eledon’s Anti-CD40L Change Transplant Medicine?

Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.   

Eledon CEO Hopes Tegoprubart Will Be The Cornerstone Of Transplant Immunosuppression • Source: Shutterstock

More from Innovation

More from In Vivo